Digit health technologies (DHT) are a key aspect of U.S. Health & Human Services (HHS) Secretary Robert F. Kennedy Jr.’s Make America Healthy ...

Clinical research is in the midst of a data explosion, and that’s a good thing. Technological advances are enabling access to secure and de-identified data sources for researchers, and the ...

Sunbird Bio, a biotechnology company developing proprietary blood-based technologies to improve diagnosis and treatment of ...

Commissioner Marty Makary said that the FDA will soon start requiring only one pivotal trial, instead of two, for companies ...

The pharmaceutical and medical device industries stand at an inflection point. After decades of reliance on traditional ...

Investors, analysts, doctors, and even patients face an avalanche of news from biotech companies about their human trials of experimental drugs, and wading through all that data to draw reasonable ...

Failure is endemic to clinical trials, with roughly 9 in 10 drug candidates not reaching market. But could virtual patients — vis-à-vis, synthetic data — make for more successful research questions?

In today’s ultra-competitive global marketplace, life sciences companies are continually seeking ways to improve their research effectiveness and efficiency. Increasingly, real-world data (RWD) is ...

The global clinical trials market is anticipated to grow at a CAGR of 6-7% from 2024 to 2029. This growth is driven by the ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel neuroplastogen-derived therapeutics ...